Oropharyngeal Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Oropharyngeal Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-08-15Clinical Trial Update: Phase II Study of Atezolizumab and Tiragolumab With ctDNA for HPV-positive SCC [Phase 2]
Phase II study of atezolizumab and tiragolumab with ctDNA for HPV-positive oropharyngeal squamous cell carcinoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-07-31Clinical Trial Update: Saliva Testing for High-Risk Human Papillomavirus Infection Oral Cavity and Pharynx Cancer
A clinical trial evaluating saliva testing for high-risk human papillomavirus infection in oral cavity and oropharyngeal cancers has been wi…
-
CLINICAL_TRIALS withdrawal · 2025-07-11Clinical Trial Update: A Window of Opportunity Study of Black Raspberry for Patients With HNSCC [EARLY_Phase 1]
An early-phase 1 trial evaluating black raspberry for patients with squamous cell carcinoma of the oral cavity or oropharynx has been withdr…
-
CLINICAL_TRIALS withdrawal · 2025-06-22Clinical Trial Update: A Study of HB-202/HB-201 With Pembrolizumab in Patients With HPV16+ Recurrent/Metastatic Oropharyngeal Cancer [Phase 2, Phase 3]
A Phase 2/Phase 3 trial evaluating HB-202/HB-201 with pembrolizumab in HPV16-positive recurrent/metastatic oropharyngeal squamous cell carci…
-
CLINICAL_TRIALS withdrawal · 2025-04-04Clinical Trial Update: Vorinostat in Combination With Chemoradiation in Locally Advanced HPV Negative HNSCC [Phase 2]
Phase 2 trial of vorinostat with chemoradiation for locally advanced head and neck squamous cell carcinoma has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2025-02-14Clinical Trial Update: NT-I7 for the Treatment of Recurrent Squamous Cell Carcinoma of Head and Neck Undergoing Surgery [Phase 1]
A Phase 1 trial of NT-I7 for recurrent squamous cell carcinoma of the head and neck undergoing surgery was terminated.
-
CLINICAL_TRIALS withdrawal · 2024-07-25Clinical Trial Update: Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck Cancer [Phase 2]
Phase 2 trial evaluating Xevinapant added to standard radiation therapy plus cisplatin/carboplatin for head and neck cancers has been withdr…
-
CLINICAL_TRIALS withdrawal · 2017-11-13Clinical Trial Update: Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell Carcinoma [Phase 1, Phase 2]
A clinical trial evaluating cetuximab, cisplatin, and BYL719 for HPV-associated oropharyngeal squamous cell carcinoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-09-04Clinical Trial Update: Stereotactic Boost for Oropharyngeal Squamous Cell Carcinoma [Phase 1, Phase 2]
This clinical trial update notes that the Phase 1/Phase 2 study of a stereotactic boost for oropharyngeal squamous cell carcinoma has been w…
-
CLINICAL_TRIALS withdrawal · 2015-03-20Clinical Trial Update: Radiation Therapy and Cisplatin With or Without Surgery in Treating Patients With Stage III-IV Oropharyngeal Cancer [Phase 2]
Phase 2 trial evaluating radiation therapy and cisplatin with or without surgery for stage III-IV oropharyngeal cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-09-03Clinical Trial Update: Photodynamic Therapy Using Temoporfin Before Surgery in Treating Patients With Recurrent Oral Cavity or Oropharyngeal Cancer [NA]
A clinical trial investigating photodynamic therapy with temoporfin before surgery for recurrent oral cavity and oropharyngeal cancers has b…